Atrin Pharmaceuticals is a private biopharmaceutical company pioneering the discovery & development of proprietary molecules targeting DNA Damage and Response (DDR) pathways to treat a broad spectrum of cancers associated with synthetic lethality and the deregulated DNA Damage Response. 



Biotechnology

Pharmaceutical

Therapeutics

Atrin Pharmaceuticals

Atrin Pharmaceuticals' headquarters in Ambler, PA, United States

Zeev Weiss

Michel Afargan

Molly Hansbarger

Michael Grissinger

Marc Duey

Renold Capocasale

Timothy Yap

Karen E. Knudsen

Zvi Gregorio Fridlender

Bernard Rudnick

Rifat Pamucku

Jay Rosan

Jeffrey Dayno

Geoffrey I. Shapiro

Eric Brown

Description